CCL vs DMAC · P/E 15, rev $25.02B vs $157.4M cap
Carnival Corporation (CCL) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
DMAC does not have a complete income-statement cache yet.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CCL and DMAC stock pages for the full models.
Not investment advice.